Recent Articles
The trouble with tech M&A
May 15, 2012 : M&A
U.S. M&A volume may be at the lowest level since early 2003, but technology deals are on a tear more »
Can Pharma Turn the Oceanliner Around?
May 14, 2012 : Big Pharma
In introducing biotech guru G. Steven Burrill today, Illinois BIO (iBIO) president David Miller likened the speaker to the Michael Jordan of biotechnology. “There will never be the next Steven Burrill,” he said. “At a critical time in biotech’s development, he was there.” more »
Dealmakers weekly review – May 7 2012 – Royalty Pharma, Fumapharm, Pfizer, Quark, Novartis, Fougera, Hologic, Gen-Probe
May 8, 2012 : dealtalk
Partnering buoyant with numerous bigpharma deals annnounced in the past week. M&A also saw several billion dollar deals more »
CurrentAgreements Deals Update: May 2012
May 8, 2012 : dealtalk
This month we are providing you with an overview of deal making activity in the life sciences, covering partnering and M&A in April 2012 more »
Can portfolio theory save lives?
May 8, 2012 : dealtalk
With U.S. biomedical research under assault by everyone from patients to Congress for turning so few scientific discoveries into treatments, a leading finance expert says decisions about what studies to bankroll should be made the same way pension funds, mutual funds, and university endowments decide how to invest their money more »
Points of view
Hologic buys Gen-Probe for $3.7 billion
May 1, 2012
In a joint statement, Hologic announced it is to acquire Gen-Probe, in a deal valued at $37 billion more »
Jazz makes another acquisition, this time Eusa
April 30, 2012
A mere few months after acquiring Azur Pharma, Jazz is at it again, this time acquiring Eusa Pharma for $700 million more »
AstraZeneca acquires Ardea for $1.26 billion; gains Lesinurad
April 25, 2012
In a deal valued at $1.26 billion, AstraZeneca has snapped up Ardea Biosciences, gaining access to Ardea’s lead drug for the treatment of gout, Lesinurad, in the process more »
Glossary
Royalty financing
April 26, 2012
Top 50 Pharma
July 1, 2011
Two-step merger
April 5, 2011
Second-step merger
April 5, 2011
Warranties
April 3, 2011
